Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 5:10:e63704.
doi: 10.7554/eLife.63704.

Quantifying the impact of quarantine duration on COVID-19 transmission

Affiliations

Quantifying the impact of quarantine duration on COVID-19 transmission

Peter Ashcroft et al. Elife. .

Abstract

The large number of individuals placed into quarantine because of possible severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) exposure has high societal and economic costs. There is ongoing debate about the appropriate duration of quarantine, particularly since the fraction of individuals who eventually test positive is perceived as being low. We use empirically determined distributions of incubation period, infectivity, and generation time to quantify how the duration of quarantine affects onward transmission from traced contacts of confirmed SARS-CoV-2 cases and from returning travellers. We also consider the roles of testing followed by release if negative (test-and-release), reinforced hygiene, adherence, and symptoms in calculating quarantine efficacy. We show that there are quarantine strategies based on a test-and-release protocol that, from an epidemiological viewpoint, perform almost as well as a 10-day quarantine, but with fewer person-days spent in quarantine. The findings apply to both travellers and contacts, but the specifics depend on the context.

Keywords: COVID-19; SARS-CoV-2; contact tracing; epidemic containment; epidemiology; global health; human; medicine; quarantine.

Plain language summary

The COVID-19 pandemic has led many countries to impose quarantines, ensuring that people who may have been exposed to the SARS-CoV-2 virus or who return from abroad are isolated for a specific period to prevent the spread of the disease. These measures have crippled travel, taken a large economic toll, and affected the wellbeing of those needing to self-isolate. However, there is no consensus on how long COVID-19 quarantines should be. Reducing the duration of quarantines could significantly decrease the costs of COVID-19 to the overall economy and to individuals, so Ashcroft et al. decided to examine how shorter isolation periods and test-and-release schemes affected transmission. Existing data on how SARS-CoV-2 behaves in a population were used to generate a model that would predict how changing quarantine length impacts transmission for both travellers and people who may have been exposed to the virus. The analysis predicted that shortening quarantines from ten to seven days would result in almost no increased risk of transmission, if paired with PCR testing on day five of isolation (with people testing positive being confined for longer). The quarantine could be cut further to six days if rapid antigen tests were used. Ashcroft et al.’s findings suggest that it may be possible to shorten COVID-19 quarantines if good testing approaches are implemented, leading to better economic, social and individual outcomes.

PubMed Disclaimer

Conflict of interest statement

PA, SL, DA, NL, SB No competing interests declared

Figures

Figure 1.
Figure 1.. Quantifying the impact of quarantine using a mathematical model.
Here the y-axis represents the probability of transmission. These infectivity curves are a schematic representation of the generation time distribution shown in Figure 1—figure supplement 1. (A) Traced contacts are exposed to an infector at a known time t_E=0 and then enter quarantine at time t_Q. Some transmission can occur prior to quarantine. Under the standard quarantine protocol, the contact is quarantined until time t_R, and no transmission is assumed to occur during this time. The area under the infectivity curve between t_Q and t_R (blue) is the fraction of transmission that is prevented by quarantine. Transmission can occur after the individual leaves quarantine. Under the test-and-release protocol, quarantined individuals are tested at time t_T and released at time t_R if they receive a negative test result. Otherwise the individual is isolated until they are no longer infectious. The probability that an infected individual returns a false-negative test result, and therefore is prematurely released, depends on the timing of the test relative to infection (t_T-t_E) (Kucirka et al., 2020). (B) For returning travellers, the time of exposure t_E is unknown and we assume that infection could have occurred on any day of the trip. The travellers enter quarantine immediately upon return at time t_Q=0, and then leave quarantine at time t_R under the standard quarantine protocol. Test-and-release quarantine proceeds as in panel A.
Figure 1—figure supplement 1.
Figure 1—figure supplement 1.. Infection timing distributions.
(A) The timeline of infection for an infector–infectee transmission pair. The generation time is defined as the time interval between subsequent infections (t_2-t_1), while the serial interval is defined as the time between symptoms onsets in this transmission pair (t_S_2-t_S_1). The incubation period describes the time between infection and symptom onset in a single individual (e.g. t_S_1-t_1). (B) The generation time distribution follows a Weibull distribution and is inferred from the serial interval distribution (Ferretti et al., 2020b). (C) The infectivity profile (describing the time between symptom onset in the infector and infection of the infectee) follows a shifted Student’s t-distribution and is also inferred from the serial interval distribution (Ferretti et al., 2020b). (D) The distribution of incubation times follows a meta-distribution constructed from the average of seven reported log-normal distributions (Bi et al., 2020; Jiang et al., 2020; Lauer et al., 2020; Li et al., 2020; Linton et al., 2020; Ma et al., 2020; Zhang et al., 2020), as described in Ferretti et al., 2020b.
Figure 2.
Figure 2.. Quantifying the impact of quarantine for traced contacts.
(A) The fraction of transmission that is prevented by quarantining an infected contact. Quarantine begins at time t_Q=3 after exposure at time t_E=0, that is, there is a 3-day delay between exposure and the start of quarantine. Under the standard quarantine protocol (black), individuals are released without being tested [Equation (1)]. The test-and-release protocol (colours) requires a negative test result before early release, otherwise individuals remain isolated until they are no longer infectious (day 10) [Equation (2)]. Colour intensity represents the delay between test and release (from 0 to 3 days). The grey line represents the maximum attainable prevention by increasing the time of release while keeping t_Q=3 fixed. (B) The relative utility of the quarantine scenarios in A compared to the standard protocol 10-day quarantine [Equation (6)]. Utility is defined as the fraction of transmission prevented per day spent in quarantine. The grey line represents equal utilities (relative utility of 1). We assume that the fraction of individuals in quarantine that are infected is 10%, and that there are no false-positive test results. Error bars reflect the uncertainty in the generation time distribution.
Figure 2—figure supplement 1.
Figure 2—figure supplement 1.. Quantifying the effect of duration and delay for the standard quarantine protocol (no test) for traced contacts.
(A) The fraction of transmission that is prevented by quarantining an infected contact [Equation (1)]. We fix the time of exposure to t_E=0, and quarantine begins after a delay of 0–4 days (colour). (B) The relative utility of different quarantine durations compared to release on day 10 [Equation (5)]. Error bars reflect the uncertainty in the generation time distribution.
Figure 2—figure supplement 2.
Figure 2—figure supplement 2.. Quantifying the impact of quarantine and reinforced hygiene measures for traced contacts.
(A) The fraction of transmission that is prevented by quarantining an infected contact and enforcing strict hygiene measures after release (see 'Appendix 1: Reinforced prevention measures after early release' for details). The scenarios are the same as in Figure 2 (i.e. exposure at time t_E=0 and quarantine entry at time t_Q=3), but we reduce post-quarantine transmission by r=50% until day 10, after which further transmission is unlikely. The grey line represents the maximum attainable prevention by increasing release time, but keeping t_Q=3 fixed. (B) The relative utility of the quarantine and hygiene scenarios in panel A compared to the standard protocol 10-day quarantine [Equation 6]. The grey line represents equal utilities (relative utility of 1). We assume that the fraction of individuals in quarantine that are infected is s=10%, and that there are no false-positive test results. Error bars reflect the uncertainty in the generation time distribution.
Figure 3.
Figure 3.. How adherence and symptoms affect quarantine efficacy for traced contacts.
(A) The fold-change in adherence to a new quarantine strategy that is required to maintain efficacy of the baseline 10-day standard strategy. Quarantine strategies are the same as in Figure 2 (standard = black, test-and-release = colours). The grey line represents equal adherence (relative adherence of 1). (B) The impact of symptomatic cases on the fraction of total onward transmission per infected traced contact that is prevented by standard (no test) quarantine [Equation (A9)]. We assume that symptomatic individuals will immediately self-isolate at symptom onset. The time of symptom onset is determined by the incubation period distribution (see Figure 1—figure supplement 1D). The curve for 100% asymptomatic cases corresponds to the black curve in Figure 2A. As in Figure 2, we fix the time of exposure at t_E=0 and the time of entering quarantine at t_Q=3 days. Error bars reflect the uncertainty in the generation time distribution.
Figure 3—figure supplement 1.
Figure 3—figure supplement 1.. How the delay between symptom onset and self-isolation affects quarantine efficacy for traced contacts.
The y-axis is the fraction of total onward transmission per infected traced contact that is prevented by standard (no test) quarantine [Equation (A9)]. Each panel corresponds to a different delay between symptom onset and self-isolation in symptomatic individuals. The left-most panel (zero delay) corresponds to Figure 3B. The time of symptom onset is determined by the incubation period distribution (see Figure 1—figure supplement 1D). As in Figures 2 and 3, we fix the time of exposure at t_E=0 and the time of entering quarantine at t_Q=3 days. Error bars reflect the uncertainty in the generation time distribution.
Figure 4.
Figure 4.. Quantifying the impact of quarantine for returning travellers.
(A) The fraction of local transmission that is prevented by quarantining an infected traveller returning from a 7-day trip. Quarantine begins upon return at time t_Q=0, and we assume that exposure could have occurred at any time during the trip, that is, -7t_E0. Under the standard quarantine protocol (black), individuals are released without being tested [Equation (9)]. The test-and-release protocol (colours) requires a negative test result before early release, otherwise individuals remain isolated until they are no longer infectious (day 10). Colour intensity represents the delay between test and release (from 0 to 3 days). While extended quarantine can prevent 100% of local transmission (grey line), this represents 73.3% [CI: 65.7%,80.3%] of the total transmission potential (see Figure 4—figure supplement 1A). The remaining transmission occurred before arrival. (B) The relative utility of the quarantine scenarios in A compared to the standard protocol 10-day quarantine [Equation 6]. Utility is defined as the local fraction of transmission that is prevented per day spent in quarantine. The grey line represents equal utilities (relative utility of 1). We assume that the fraction of individuals in quarantine that are infected is 10%, and that there are no false-positive test results. Error bars reflect the uncertainty in the generation time distribution.
Figure 4—figure supplement 1.
Figure 4—figure supplement 1.. Quantifying the effect of travel duration and quarantine duration for the standard quarantine protocol (no test) for returning travellers.
(A) The fraction of total transmission that is prevented by quarantining an infected traveller [Equation (7)]. (B) The relative utility of the different quarantine durations in A compared to release on day 10, based on the total fraction of transmission prevented. (C) The fraction of local transmission that is prevented by quarantining an infected traveller [Equation (9)]. (D) The relative utility of the different quarantine durations in C compared to release on day 10, based on the local fraction of transmission prevented. Colours represent the duration of travel y, and we assume that infection can occur with equal probability on each day t_E which satisfies -yt_E0. Quarantine begins at time t_Q=0, which is the time of arrival. Error bars reflect the uncertainty in the generation time distribution.
Figure 4—figure supplement 2.
Figure 4—figure supplement 2.. Quantifying the impact of quarantine and reinforced hygiene measures for returning travellers.
(A) The fraction of local transmission that is prevented by quarantining an infected traveller and enforcing strict hygiene measures after release (see 'Appendix 1: Reinforced prevention measures after early release' for details). The scenarios are the same as in Figure 4 (i.e. exposure occurs with equal probability between day –7 and return at day 0, -yt_E0, and quarantine starts at time t_Q=0), but we reduce post-quarantine transmission by r=50% until day 10, after which further transmission is unlikely. (B) The relative utility of the quarantine and hygiene scenarios in A compared to the standard protocol 10-day quarantine [Equation 6]. We assume that the fraction of individuals in quarantine that are infected is 10%, and that there are no false-positive test results. Error bars reflect the uncertainty in the generation time distribution.
Figure 4—figure supplement 3.
Figure 4—figure supplement 3.. How adherence and symptoms affect quarantine efficacy for returning travellers.
(A) The fold-change in adherence to a new quarantine strategy that is required to maintain efficacy (local fraction of transmission prevented) of the baseline 10-day standard strategy. Quarantine strategies are the same as in Figure 4 (standard = black, test-and-release = colours). The grey line represents equal adherence (relative adherence of 1). (B) The impact of symptomatic cases on the fraction of local transmission per infected traveller that is prevented by standard (no test) quarantine [Equation (A9)]. We assume that symptomatic individuals will immediately self-isolate at symptom onset. The time of symptom onset is determined by the incubation period distribution (see Figure 1—figure supplement 1D). The curve for a=100% corresponds to the black curve in Figure 4A. For both panels, as in Figure 4, we fix the trip duration to 7 days and assume exposure can occur at any time -yt_E0. Quarantine begins at time t_Q=0. Error bars reflect the uncertainty in the generation time distribution.
Appendix 1—figure 1.
Appendix 1—figure 1.. Log-likelihood values [ln(θ)-ln(θ^)] for random parameter samples of the generation time distribution.
These samples define the 95% confidence interval for the generation time distribution parameters. Red dot is the maximum likelihood parameter combination as shown in Appendix 1—table 1.

Comment in

  • Should I stay or should I go?
    Kretzschmar M, Müller J. Kretzschmar M, et al. Elife. 2021 Mar 16;10:e67417. doi: 10.7554/eLife.67417. Elife. 2021. PMID: 33722343 Free PMC article.

References

    1. Ali ST, Wang L, Lau EHY, Xu XK, Du Z, Wu Y, Leung GM, Cowling BJ. Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science. 2020;369:1106–1109. doi: 10.1126/science.abc9004. - DOI - PMC - PubMed
    1. Ashcroft P, Huisman JS, Lehtinen S, Bouman JA, Althaus CL, Regoes RR, Bonhoeffer S. COVID-19 infectivity profile correction. Swiss Medical Weekly. 2020;150:w20336. doi: 10.4414/smw.2020.20336. - DOI - PubMed
    1. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, Gao W, Cheng C, Tang X, Wu X, Wu Y, Sun B, Huang S, Sun Y, Zhang J, Ma T, Lessler J, Feng T. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. The Lancet Infectious Diseases. 2020;20:911–919. doi: 10.1016/S1473-3099(20)30287-5. - DOI - PMC - PubMed
    1. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet. 2020;395:912–920. doi: 10.1016/S0140-6736(20)30460-8. - DOI - PMC - PubMed
    1. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, Salanti G, Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLOS Medicine. 2020;17:e1003346. doi: 10.1371/journal.pmed.1003346. - DOI - PMC - PubMed

Publication types